Headline
The latest stories from AHA Today.
The AHA urged the Centers for Medicare & Medicaid Services not to resume medical review activities, including Recovery Audit Contractor-initiated audits, which CMS suspended on March 30 due to the COVID-19 public health emergency.
Six national organizations representing hospitals, including the AHA, urged the Centers for Medicare & Medicaid Services to delay the start of repayments associated with the Medicare Accelerated and Advance Payment Programs. The first hospitals and health systems to receive accelerated payments…
A blog co-authored by Elisa Arespacochaga, vice president of AHA’s Physician Alliance and interim executive lead of AHA’s Institute for Diversity and Health Equity, and Derek Robinson, M.D., vice president and chief medical officer at Blue Cross and Blue Shield of Illinois, highlights the 13 newly…
The Cleveland Clinic will partner with the Health Education Campus of Case Western Reserve University to host on Tuesday, Sept. 29, the first presidential debate between presumptive nominees Republican Donald Trump and Democrat Joe Biden, the Commission on Presidential Debates announced.
A new AHA issue brief outlines five actions that hospitals and health systems can take to address housing instability and improve health in their communities during COVID-19.
Kittitas Valley Healthcare in Ellensburg, Wash., was among the nation’s first hospitals to feel the impact of COVID-19.
The Food and Drug Administration issued emergency use authorizations to Xiamen Biotime Biotechnology Co. and Access Bio Inc. for serology-based tests to detect SARS-CoV-2 antibodies indicating recent or prior infection.
The U.S. International Development Finance Corporation signed a letter of interest to provide a $765 million loan to Eastman Kodak Company to repurpose and expand its facilities in Rochester, N.Y., and St. Paul, Minn., to produce active pharmaceutical ingredients in short supply.
The Department of Health and Human Services’ Biomedical Advanced Research and Development Authority issued a $265 million task order reserving vaccine manufacturing capacity through December 2021 at an advanced manufacturing center in Texas.
The Centers for Medicare & Medicaid Services released an updated snapshot of the impact of COVID-19 on the Medicare population, which includes COVID-19 cases and hospitalizations through June 20 and the first data for American Indian/Alaskan Native Medicare beneficiaries.